Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global GM1 Gangliosidosis Market Report 2025

GM1 Gangliosidosis Global Market Report 2025 - By Disease Type (Type 1 GM1 Gangliosidosis, Type 2 GMT Gangliosidosis, Type 3 GMT Gangliosidosis), By Treatment (Anticonvulsants, Bone Marrow Transplantation, Cord-Blood Hematopoietic Stem-Cell Transplantation, Enzyme Replacement, Gene Therapy), By End-User (Research Institutes, Hospitals, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

GM1 Gangliosidosis Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
GM1 Gangliosidosis Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under GM1 Gangliosidosis Market

GM1 gangliosidosis is a rare, inherited neurodegenerative disorder caused by a deficiency of the ß-galactosidase (GLB1) enzyme, leading to toxic accumulation of GM1 gangliosides in the brain and other tissues. It results in progressive neurological decline, developmental delays, muscle weakness, and organ enlargement.

The main disease types in GM1 gangliosidosis are type 1 GM1 gangliosidosis, type 2 GMT gangliosidosis, and type 3 GMT gangliosidosis. Type 1 GM1 gangliosidosis is the most severe form, diagnosed in infancy, characterized by rapid neurological degeneration. Affected children experience progressive motor and cognitive decline, resulting in early death. Treatment options include anticonvulsants, bone marrow transplantation, cord-blood hematopoietic stem cell transplantation, enzyme replacement therapy, and gene therapy. These are utilized in research institutes, hospitals, and others.

How Is The GM1 Gangliosidosis Market Segmented?

The GM1 gangliosidosis market covered in this report is segmented –

1) By Disease Type: Type 1 GM1 Gangliosidosis, Type 2 GMT Gangliosidosis, Type 3 GMT Gangliosidosis

2) By Treatment: Anticonvulsants, Bone Marrow Transplantation, Cord-Blood Hematopoietic Stem-Cell Transplantation, Enzyme Replacement, Gene Therapy

3) By End-User: Research Institutes, Hospitals, Other End-Users

Subsegments:

1) By Type 1 GM1 Gangliosidosis: Classic Infantile Onset, Atypical Infantile Onset

2) By Type 2 GM1 Gangliosidosis: Classic Juvenile Onset, Atypical Juvenile Onset

3) By Type 3 GM1 Gangliosidosis: Classic Adult Onset, Atypical Adult Onset

GM1 Gangliosidosis Market Size and growth rate 2025 to 2029: Graph

What Is The GM1 Gangliosidosis Market Size 2025 And Growth Rate?

The GM1 gangliosidosis market size has grown rapidly in recent years. It will grow from $0.51 billion in 2024 to $0.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increase in number of patients suffering from gm1 gangliosidosis, growing area of focus in the gm1 gangliosidosis space, rising prevalence of rare disease awareness, rising popularity of patient-centric research, and increasing focus on early intervention.

What Is The GM1 Gangliosidosis Market Growth Forecast?

The GM1 gangliosidosis market size is expected to see rapid growth in the next few years. It will grow to $0.87 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing gm1 gangliosidosis cases, rising lysosomal storage disorder, rising number of clinical trials, increasing focus on gene therapy and editing, increasing personalized and precision medicine, and rising adoption of genetic screening programs. Major trends in the forecast period include advancements in gene-editing technologies, integration of technology in healthcare, advancement in diagnostic techniques, advanced formulations, and advancements in genetic therapies.

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The GM1 Gangliosidosis Market: Rising Adoption Of Gene Therapy Fuels Growth In Rare Disease Treatments

The increasing adoption of gene therapy is expected to fuel the growth of the GM1 gangliosidosis market going forward. Gene therapy is a medical treatment that involves altering or replacing genes within a person's cells to treat or prevent disease. The increasing adoption of gene therapy is driven by advancements in genetic research, improved treatment outcomes for previously untreatable conditions, and growing regulatory support for innovative therapies. Gene therapy for GM1 gangliosidosis involves delivering a functional copy of the defective gene (GLB1) to patient cells to restore ß-galactosidase enzyme activity and reduce toxic substrate buildup. For instance, in April 2024, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, in the fourth quarter, the number of phase III gene therapy clinical trials rose by 10%, marking the first quarterly increase since the third quarter of 2022. Therefore, the increasing adoption of gene therapy is driving the growth of the GM1 gangliosidosis market.

Who Are The Major Players In The Global GM1 Gangliosidosis Market?

Major companies operating in the GM1 gangliosidosis market are Pfizer Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Sarepta Therapeutics Inc., CRISPR Therapeutics AG, REGENXBIO Inc., Passage Bio Inc., Orchard Therapeutics plc, AVROBIO Inc., uniQure N.V., GEMMA Biotherapeutics Inc., Lysogene S.A., AZAFAROS B.V., BioStrategies LC, Sio Gene Therapies Inc., Gain Therapeutics Inc., Dorphan S.A., bluebird bio Inc., Axovant Gene Therapies Ltd., SphinCS GmbH.

What Are The Key Trends Of The Global GM1 Gangliosidosis Market: Strategic Partnership To Advance Gene Therapies For Rare Diseases

Major companies operating in the GM1 gangliosidosis market are focusing on strategic partnerships to sustain their position in the market. Strategic partnerships play a crucial role in advancing gene therapy development by combining expertise, resources, and technologies to accelerate research, clinical trials, and commercialization. For instance, in October 2024, GEMMA Biotherapeutics Inc., a US-based biotechnology company, partnered with Oswaldo Cruz Foundation (Fiocruz), a Brazil-based health research institution, to develop gene therapies for rare diseases, including GM1 gangliosidosis. The agreement involves up to $100 million in funding from Fiocruz for clinical research and manufacturing, aimed at making these advanced therapies accessible through Brazil's public healthcare system. This collaboration emphasizes technology transfer and aims to democratize access to treatments that were previously limited to higher-income populations.

What Are Latest Mergers And Acquisitions In The GM1 Gangliosidosis Market: Passage Bio Partners With GEMMA Biotherapeutics To Advance Pediatric Gene Therapies

In August 2024, Passage Bio Inc., a US-based biotech company, partnered with GEMMA Biotherapeutics, to advance pediatric gene therapies. As part of this collaboration, Passage Bio is out-licensing three pediatric gene therapies targeting lysosomal storage diseases including PBGM01 for GM1 gangliosidosis, PBKR03 for Krabbe disease, and PBML04 for metachromatic leukodystrophy. GEMMA Biotherapeutics Inc. is a US-based biotechnology research company that specializes in developing and commercializing genetic medicines for rare pediatric diseases.

What Is The Regional Outlook For The Global GM1 Gangliosidosis Market?

North America was the largest region in the GM1 gangliosidosis market in 2024. The regions covered in the GM1 gangliosidosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the GM1 gangliosidosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the GM1 Gangliosidosis  Market?

The GM1 gangliosidosis market consists of revenues earned by entities by providing services such as gene therapy, diagnostic testing, patient care, and clinical trials. The market value includes the value of related goods sold by the service provider or included within the service offering. The GM1 gangliosidosis market also includes sales of diagnostic tools, research kits, biomarkers, and assistive devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the GM1 Gangliosidosis  Industry?

The GM1 gangliosidosis market research report is one of a series of new reports from The Business Research Company that provides GM1 gangliosidosis market statistics, including GM1 gangliosidosis industry global market size, regional shares, competitors with a GM1 gangliosidosis market share, detailed GM1 gangliosidosis market segments, market trends and opportunities, and any further data you may need to thrive in the GM1 gangliosidosis industry. This GM1 gangliosidosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

GM1 Gangliosidosis Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $0.57 billion
Revenue Forecast In 2034 $0.87 billion
Growth Rate CAGR of 11.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The GM1 gangliosidosis market covered in this report is segmented –
1) By Disease Type: Type 1 GM1 Gangliosidosis, Type 2 GMT Gangliosidosis, Type 3 GMT Gangliosidosis
2) By Treatment: Anticonvulsants, Bone Marrow Transplantation, Cord-Blood Hematopoietic Stem-Cell Transplantation, Enzyme Replacement, Gene Therapy
3) By End-User: Research Institutes, Hospitals, Other End-Users Subsegments:
1) By Type 1 GM1 Gangliosidosis: Classic Infantile Onset, Atypical Infantile Onset
2) By Type 2 GM1 Gangliosidosis: Classic Juvenile Onset, Atypical Juvenile Onset
3) By Type 3 GM1 Gangliosidosis: Classic Adult Onset, Atypical Adult Onset
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Sarepta Therapeutics Inc., CRISPR Therapeutics AG, REGENXBIO Inc., Passage Bio Inc., Orchard Therapeutics plc, AVROBIO Inc., uniQure N.V., GEMMA Biotherapeutics Inc., Lysogene S.A., AZAFAROS B.V., BioStrategies LC, Sio Gene Therapies Inc., Gain Therapeutics Inc., Dorphan S.A., bluebird bio Inc., Axovant Gene Therapies Ltd., SphinCS GmbH.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. GM1 Gangliosidosis Market Characteristics

    3. GM1 Gangliosidosis Market Trends And Strategies

    4. GM1 Gangliosidosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global GM1 Gangliosidosis Growth Analysis And Strategic Analysis Framework

    5.1. Global GM1 Gangliosidosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global GM1 Gangliosidosis Market Growth Rate Analysis

    5.4. Global GM1 Gangliosidosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global GM1 Gangliosidosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global GM1 Gangliosidosis Total Addressable Market (TAM)

    6. GM1 Gangliosidosis Market Segmentation

    6.1. Global GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Type 1 GM1 Gangliosidosis

    Type 2 GMT Gangliosidosis

    Type 3 GMT Gangliosidosis

    6.2. Global GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Anticonvulsants

    Bone Marrow Transplantation

    Cord-Blood Hematopoietic Stem-Cell Transplantation

    Enzyme Replacement

    Gene Therapy

    6.3. Global GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Research Institutes

    Hospitals

    Other End-Users

    6.4. Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 1 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Classic Infantile Onset

    Atypical Infantile Onset

    6.5. Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 2 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Classic Juvenile Onset

    Atypical Juvenile Onset

    6.6. Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 3 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Classic Adult Onset

    Atypical Adult Onset

    7. GM1 Gangliosidosis Market Regional And Country Analysis

    7.1. Global GM1 Gangliosidosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global GM1 Gangliosidosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific GM1 Gangliosidosis Market

    8.1. Asia-Pacific GM1 Gangliosidosis Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China GM1 Gangliosidosis Market

    9.1. China GM1 Gangliosidosis Market Overview

    9.2. China GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India GM1 Gangliosidosis Market

    10.1. India GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan GM1 Gangliosidosis Market

    11.1. Japan GM1 Gangliosidosis Market Overview

    11.2. Japan GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia GM1 Gangliosidosis Market

    12.1. Australia GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia GM1 Gangliosidosis Market

    13.1. Indonesia GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea GM1 Gangliosidosis Market

    14.1. South Korea GM1 Gangliosidosis Market Overview

    14.2. South Korea GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe GM1 Gangliosidosis Market

    15.1. Western Europe GM1 Gangliosidosis Market Overview

    15.2. Western Europe GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK GM1 Gangliosidosis Market

    16.1. UK GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany GM1 Gangliosidosis Market

    17.1. Germany GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France GM1 Gangliosidosis Market

    18.1. France GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy GM1 Gangliosidosis Market

    19.1. Italy GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain GM1 Gangliosidosis Market

    20.1. Spain GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe GM1 Gangliosidosis Market

    21.1. Eastern Europe GM1 Gangliosidosis Market Overview

    21.2. Eastern Europe GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia GM1 Gangliosidosis Market

    22.1. Russia GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America GM1 Gangliosidosis Market

    23.1. North America GM1 Gangliosidosis Market Overview

    23.2. North America GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA GM1 Gangliosidosis Market

    24.1. USA GM1 Gangliosidosis Market Overview

    24.2. USA GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada GM1 Gangliosidosis Market

    25.1. Canada GM1 Gangliosidosis Market Overview

    25.2. Canada GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America GM1 Gangliosidosis Market

    26.1. South America GM1 Gangliosidosis Market Overview

    26.2. South America GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil GM1 Gangliosidosis Market

    27.1. Brazil GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East GM1 Gangliosidosis Market

    28.1. Middle East GM1 Gangliosidosis Market Overview

    28.2. Middle East GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa GM1 Gangliosidosis Market

    29.1. Africa GM1 Gangliosidosis Market Overview

    29.2. Africa GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. GM1 Gangliosidosis Market Competitive Landscape And Company Profiles

    30.1. GM1 Gangliosidosis Market Competitive Landscape

    30.2. GM1 Gangliosidosis Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. GM1 Gangliosidosis Market Other Major And Innovative Companies

    31.1. CRISPR Therapeutics AG

    31.2. REGENXBIO Inc.

    31.3. Passage Bio Inc.

    31.4. Orchard Therapeutics plc

    31.5. AVROBIO Inc.

    31.6. uniQure N.V.

    31.7. GEMMA Biotherapeutics Inc.

    31.8. Lysogene S.A.

    31.9. AZAFAROS B.V.

    31.10. BioStrategies LC

    31.11. Sio Gene Therapies Inc.

    31.12. Gain Therapeutics Inc.

    31.13. Dorphan S.A.

    31.14. bluebird bio Inc.

    31.15. Axovant Gene Therapies Ltd.

    32. Global GM1 Gangliosidosis Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The GM1 Gangliosidosis Market

    34. Recent Developments In The GM1 Gangliosidosis Market

    35. GM1 Gangliosidosis Market High Potential Countries, Segments and Strategies

    35.1 GM1 Gangliosidosis Market In 2029 - Countries Offering Most New Opportunities

    35.2 GM1 Gangliosidosis Market In 2029 - Segments Offering Most New Opportunities

    35.3 GM1 Gangliosidosis Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 1 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 2 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 3 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global GM1 Gangliosidosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global GM1 Gangliosidosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Sanofi S.A. Financial Performance
  • Table 79: Novartis AG Financial Performance
  • Table 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 81: Sarepta Therapeutics Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 1 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 2 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global GM1 Gangliosidosis Market, Sub-Segmentation Of Type 3 GM1 Gangliosidosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global GM1 Gangliosidosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global GM1 Gangliosidosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, GM1 Gangliosidosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, GM1 Gangliosidosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, GM1 Gangliosidosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Sanofi S.A. Financial Performance
  • Figure 79: Novartis AG Financial Performance
  • Figure 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 81: Sarepta Therapeutics Inc. Financial Performance

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Read More

Global Central Lab Market 2022 – Market Opportunities And Strategies

Read More

What Is The Biohacking Market Overview In 2022?

Read More

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

Read More

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Read More

Genetic Testing Global Market Report 2025 – By Type (Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications), By End User (Hospitals And Clinics, Diagnostic Laboratories And Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Epigenetics Global Market Report 2025 – By Product (Reagents, Enzymes, Instruments, Kits ), By Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures ), By Application (Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications ), By End-User (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2025 – By Type (Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types), By Sample (Saliva, Urine, Blood), By Technology (Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis), By Business Model (Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode), By End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Genetically Modified Fruits Global Market Report 2025 – By Type (Vegetables, Crops, Fruits, Animal Products), By Trait (Herbicide Tolerance (HR), Insect Resistance (IR), Stacked Traits (ST)), By Application (Poultry, Swine, Cattle, Dairy, Aquaculture, Pet food, Equine, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Optogenetics Global Market Report 2025 – By Product (Lasers, Actuators, Sensors), By Application (Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications), By End User (Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Genetically Modified Animal Products Global Market Report 2025 – By Form (Pellets, Crumbles, Mash, Meal Or Cake ), By Feed Type (Roughages, Concentrates), By Trait (Herbicide Tolerance (HR), Insect Resistance (IR), Stacked Traits (ST)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Genetically Modified Vegetables Global Market Report 2025 – By Type Of Modification (Transgenic, Cis-Genic, Sub-Genic, Multiple Trait Integration), By Crop (Soybean, Cotton, Maize, Oilseed Rape, Canola, Alfalfa, Other Crops), By Technique (Gene Guns, Electroporation, Microinjection, Agrobacterium, Other Techniques), By Trait (Herbicide Tolerance (HT), Insect Resistance (IR), Stacked Traits, Other Traits), By Application (Scientific Research, Agriculture Crops) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Molecular Cytogenetics Global Market Report 2025 – By Product (Instruments, Kits And Reagents, Software, Services, Consumables Or Accessories), By Technology (Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Immunohistochemistry, Karyotyping, Other Technologies), By Application (Genetic Disorders, Cancer, Personalized Medicines, Other Applications), By End-User (Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the GM1 Gangliosidosis market?

GM1 gangliosidosis is a rare, inherited neurodegenerative disorder caused by a deficiency of the ß-galactosidase (GLB1) enzyme, leading to toxic accumulation of GM1 gangliosides in the brain and other tissues. It results in progressive neurological decline, developmental delays, muscle weakness, and organ enlargement. For further insights on the GM1 Gangliosidosis market, request a sample here

How will the GM1 Gangliosidosis market drivers and restraints affect the market dynamics? What forces will shape the GM1 Gangliosidosis industry going forward?

The GM1 Gangliosidosis market major growth driver - Rising Adoption Of Gene Therapy Fuels Growth In Rare Disease Treatments. For further insights on the GM1 Gangliosidosis market, request a sample here

What is the forecast market size or the forecast market value of the GM1 Gangliosidosis market?

The GM1 Gangliosidosis market size has grown strongly in recent years. The GM1 gangliosidosis market size has grown rapidly in recent years. It will grow from $0.51 billion in 2024 to $0.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increase in number of patients suffering from gm1 gangliosidosis, growing area of focus in the gm1 gangliosidosis space, rising prevalence of rare disease awareness, rising popularity of patient-centric research, and increasing focus on early intervention. The GM1 gangliosidosis market size is expected to see rapid growth in the next few years. It will grow to $0.87 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing gm1 gangliosidosis cases, rising lysosomal storage disorder, rising number of clinical trials, increasing focus on gene therapy and editing, increasing personalized and precision medicine, and rising adoption of genetic screening programs. Major trends in the forecast period include advancements in gene-editing technologies, integration of technology in healthcare, advancement in diagnostic techniques, advanced formulations, and advancements in genetic therapies. For further insights on the GM1 Gangliosidosis market, request a sample here

How is the GM1 Gangliosidosis market segmented?

The GM1 gangliosidosis market covered in this report is segmented –
1) By Disease Type: Type 1 GM1 Gangliosidosis, Type 2 GMT Gangliosidosis, Type 3 GMT Gangliosidosis
2) By Treatment: Anticonvulsants, Bone Marrow Transplantation, Cord-Blood Hematopoietic Stem-Cell Transplantation, Enzyme Replacement, Gene Therapy
3) By End-User: Research Institutes, Hospitals, Other End-Users

Subsegments:
1) By Type 1 GM1 Gangliosidosis: Classic Infantile Onset, Atypical Infantile Onset
2) By Type 2 GM1 Gangliosidosis: Classic Juvenile Onset, Atypical Juvenile Onset
3) By Type 3 GM1 Gangliosidosis: Classic Adult Onset, Atypical Adult Onset For further insights on the GM1 Gangliosidosis market, request a sample here

Which region has the largest share of the GM1 Gangliosidosis market? What are the other regions covered in the report?

North America was the largest region in the GM1 gangliosidosis market in 2024. The regions covered in the GM1 gangliosidosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the GM1 Gangliosidosis market, request a sample here.

Who are the major players in the GM1 Gangliosidosis market?

Major companies operating in the GM1 gangliosidosis market are Pfizer Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Sarepta Therapeutics Inc., CRISPR Therapeutics AG, REGENXBIO Inc., Passage Bio Inc., Orchard Therapeutics plc, AVROBIO Inc., uniQure N.V., GEMMA Biotherapeutics Inc., Lysogene S.A., AZAFAROS B.V., BioStrategies LC, Sio Gene Therapies Inc., Gain Therapeutics Inc., Dorphan S.A., bluebird bio Inc., Axovant Gene Therapies Ltd., SphinCS GmbH. . For further insights on the GM1 Gangliosidosis market, request a sample here.

What are the key trends in the GM1 Gangliosidosis market?

Major trends in the GM1 Gangliosidosis market include Strategic Partnership To Advance Gene Therapies For Rare Diseases. For further insights on the GM1 Gangliosidosis market, request a sample here.

What are the major opportunities in the GM1 Gangliosidosis market? What are the strategies for the GM1 Gangliosidosis market?

For detailed insights on the major opportunities and strategies in the GM1 Gangliosidosis market, request a sample here.

How does the GM1 Gangliosidosis market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the GM1 Gangliosidosis market growth and SWOT analysis of the GM1 Gangliosidosis industry, request a sample here.

For detailed insights on GM1 Gangliosidosis's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the GM1 Gangliosidosis industry? request a sample here.

For detailed insights on the mergers and acquisitions in the GM1 Gangliosidosis industry,

What are the key dynamics influencing the GM1 Gangliosidosis market growth? SWOT analysis of the GM1 Gangliosidosis market. request a sample here.